节点文献
视网膜缺血-再灌注的中医研究概况
Progress in the research of Chinese medicine for retinal ischemia-reperfusion
【摘要】 目前常用的抗视网膜缺血-再灌注损伤(RIR)的药物存在抗原性差、选择性低、半寿期短等缺点,因此,许多专家学者利用中医中药的优势对RIR的治疗进行了一些深入的探讨与研究。本文作者从活血化瘀中药、益气活血中药、具有抗氧化作用中药等几个方面进行了总结。
【Abstract】 Anti ischemia-reperfusion injury drugs for retina currently being used have some defects such as antigenicity,poor selectivity and short half-life,and many experts and scholars have done a lot of research in RIR by using the advantages of Chinese medicine treatment. The author reviewed the research progress of the Chinese medicinal herbs in the aspects of blood-activating and stasis-resolving drugs,qireplenishing and blood-nourishing drugs,as well as antioxidation drugs.
- 【文献出处】 中国中医眼科杂志 ,China Journal of Chinese Ophthalmology , 编辑部邮箱 ,2009年04期
- 【分类号】R276.7
- 【被引频次】3
- 【下载频次】119